Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Sandström

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2025
Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort studyDennis Björk, Ulrik Carling, Stefan Gilg, et al.
International Journal of Surgery (London, England)|February 1, 2020
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort studyBergthor Björnsson, Kristina Hasselgren, Bård Røsok, et al.
BJS Open|March 24, 2026
Acute kidney injury after major hepatectomy: association with postoperative complications and post-hepatectomy liver failureOskar Swartling, Tim Reese, Kristina Hasselgren, et al.
Annals of Surgery|September 14, 2017
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)Per Sandström, Bård I Røsok, Ernesto Sparrelid, et al.
Oncology Reports|October 26, 2011
Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patientsYang-Mei Shen, Gunnar Arbman, Per Sandström, et al.
Annals of Surgery|February 13, 2020
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGROKristina Hasselgren, Bård I Røsok, Peter N Larsen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2018
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVOKristina Hasselgren, Per Sandström, Bård Ingvald Røsok, et al.
Future Oncology (London, England)|October 12, 2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPCOliver Sartor, Daniel George, Bertrand Tombal, et al.
Journal of Cancer Policy|April 6, 2026
Comprehensive Cancer Care in the Nordic Countries; strengths, opportunities and improvement profilesMef Nilbert, Lovisa Lesand, Maria Hernandez Mesa, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 17, 2024
Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO TrialKristina Hasselgren, Martin Henriksson, Bård I Røsok, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2025
Hyperbilirubinemia does not impair induced liver hypertrophy after portal vein Embolization-a retrospective scandinavian cohort studyDennis Björk, Ulrik Carling, Stefan Gilg, et al.
International Journal of Surgery (London, England)|February 1, 2020
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort studyBergthor Björnsson, Kristina Hasselgren, Bård Røsok, et al.
BJS Open|March 24, 2026
Acute kidney injury after major hepatectomy: association with postoperative complications and post-hepatectomy liver failureOskar Swartling, Tim Reese, Kristina Hasselgren, et al.
Annals of Surgery|September 14, 2017
ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)Per Sandström, Bård I Røsok, Ernesto Sparrelid, et al.
Oncology Reports|October 26, 2011
Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patientsYang-Mei Shen, Gunnar Arbman, Per Sandström, et al.
Annals of Surgery|February 13, 2020
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGROKristina Hasselgren, Bård I Røsok, Peter N Larsen, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 23, 2018
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVOKristina Hasselgren, Per Sandström, Bård Ingvald Røsok, et al.
Future Oncology (London, England)|October 12, 2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPCOliver Sartor, Daniel George, Bertrand Tombal, et al.
Journal of Cancer Policy|April 6, 2026
Comprehensive Cancer Care in the Nordic Countries; strengths, opportunities and improvement profilesMef Nilbert, Lovisa Lesand, Maria Hernandez Mesa, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 17, 2024
Health Economic Evaluation of Patients With Colorectal Liver Metastases Randomized to ALPPS or TSH: Analysis From the LIGRO TrialKristina Hasselgren, Martin Henriksson, Bård I Røsok, et al.
Pageof 14